En Es
Categories

EUROIMMUN AG

Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
Gold member
Products Covid-19Summary
Close

Covid-19 EUROIMMUN AG

Clinical Laboratory

COVID-19 PCR and ELISAs
COVID-19 PCR and ELISAs

EUROIMMUN’s portfolio for COVID-19 diagnostics includes the EURORealTime SARS-CoV-2 for sensitive direct virus detection, as well as ELISAs based on spike protein domain S1 (IgG, IgA) or modified nucleocapsid protein (NCP, IgG). The IgG ELISAs demonstrate specificities of 99.6% and 99.8% and sensitivities of 94.4% and 94.6%, respectively. The antibody detection can also be performed using dried blood spots taken with the Blood Collection Set. The ELISAs can be processed fully automatically, for example on the EUROLabWorkstation ELISA. All the tests are CE marked.
More details
Close

About EUROIMMUN AG

Number of Employees: 1000+
Year of Establishment: 1987
Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies
FaceBook Twitter Google+ Linked in
Autoantibody Biomarker

Autoantibody Biomarker

Model: Anti-PLA2R
Request Information

Description:

The Anti-PLA2R ELISA and the Anti-PLA2R ChLIA provide quantitative in vitro determination of antibodies against phospholipase A2 receptors. Anti-PLA2R and the supplementary marker anti-THSD7A can be detected in parallel using indirect immunofluorescence tests based on antigen-expressing cells.
Read More

Full Description

Description

The Anti-PLA2R ELISA and the Anti-PLA2R ChLIA provide quantitative in vitro determination of antibodies against phospholipase A2 receptors. Anti-PLA2R and the supplementary marker anti-THSD7A can be detected in parallel using indirect immunofluorescence tests based on antigen-expressing cells. Anti-PLA2R and anti-THS7DA antibodies are highly specific markers for primary membranous nephropathy. Their analysis supports differential diagnosis, disease monitoring, and risk assessment. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
EUROIMMUN AG (Autoantibody Biomarker)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions